RNS Number : 5136W
Legal & General UCITS ETF PLC
18 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
18/08/2020 |
IE00BFXR5Q31 |
13147267 |
USD |
168811637.00 |
12.840 |
| L&G UK Equity UCITS ETF |
18/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10824052.03 |
9.020 |
| L&G Global Equity UCITS ETF |
18/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
35543201.30 |
12.256 |
| L&G Japan Equity UCITS ETF |
18/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
123479712.08 |
11.040 |
| L&G Europe ex UK Equity UCITS ETF |
18/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
102419374.72 |
10.941 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
18/08/2020 |
IE00BFXR5W90 |
5281427 |
USD |
58017764.62 |
10.985 |
| L&G Clean Water UCITS ETF |
18/08/2020 |
IE00BK5BC891 |
1650000 |
USD |
19006799.73 |
11.519 |
| L&G Artificial Intelligence UCITS ETF |
18/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
111833043.71 |
14.074 |
| L&G Healthcare Innovation UCITS ETF |
18/08/2020 |
IE00BK5BC677 |
3100000 |
USD |
43698112.55 |
14.096 |
| L&G Pharma Breakthrough UCITS ETF |
18/08/2020 |
IE00BF0H7608 |
2000000 |
USD |
25481320.29 |
12.741 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
18/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
99302694.91 |
10.344 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
18/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
669985419.77 |
11.591 |
| L&G Battery Value-Chain UCITS ETF |
18/08/2020 |
IE00BF0M2Z96 |
14500000 |
USD |
159499909.93 |
11.000 |
| L&G Ecommerce Logistics UCITS ETF |
18/08/2020 |
IE00BF0M6N54 |
9600000 |
USD |
117227975.87 |
12.211 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
18/08/2020 |
IE00BMW3QX54 |
46130616 |
USD |
877007090.00 |
19.011 |
| L&G Cyber Security UCITS ETF |
18/08/2020 |
IE00BYPLS672 |
84356776 |
USD |
1680073577.42 |
19.916 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVZZGMRZRKGGZZ
